| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $86.28 | $24.41 | 253.44% | 162.79x | 41.46x | 10.94x | 13.21x | 1.18x | $106.92M | 1.18% | $705.78M | 6.70 | $9.23B | 1,175.92 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $31.45 | $8.35 | 276.85% | 149.76x | 72.17x | 8.85x | 17.92x | 1.28x | $39.15M | 0.95% | $220.58M | 1.69 | $4.03B | 88.84 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $232.40 | $81.80 | 184.10% | 38.10x | 35.10x | 6.46x | 22.96x | 1.31x | $793.95M | 2.56% | $1.35B | 10.14 | $32.38B | 27.45 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $95.18 | $16.06 | 492.68% | 66.56x | 80.58x | 7.87x | 10.53x | 3.05x | $197.20M | 2.65% | $710.19M | 9.08 | $7.40B | 48.71 | ||
| RPRX | ROYALTY PHARMA PLC | $64.82 | $36.98 | 75.27% | 34.48x | 11.95x | 11.38x | 3.81x | 0.69x | $2.92B | 10.13% | $9.79B | 21.99 | $45.42B | 38.62 | ||
| KRYS | KRYSTAL BIOTECH INC | $321.42 | $76.61 | 319.57% | 38.87x | 43.24x | 21.55x | 7.00x | 2.55x | $257.78M | 2.72% | $1.36B | 46.03 | $9.09B | 38.99 | ||
| VCEL | VERICEL CORP | $41.09 | $8.12 | 406.11% | 85.60x | 72.91x | 6.85x | 5.69x | 2.10x | $61.66M | 2.94% | $370.04M | 7.25 | $2.07B | 47.02 | ||
| HALO | HALOZYME THERAPEUTICS INC | $130.03 | $71.84 | 81.00% | 36.53x | 14.43x | 9.17x | 102.81x | 0.71x | $806.22M | 5.29% | $143.54M | 1.22 | $16.74B | 23.30 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.00 | $19.66 | 184.79% | 147.37x | 23.63x | 3.18x | 1.71x | 0.94x | $738.18M | 6.81% | $6.32B | 32.68 | $14.15B | 36.69 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.31 | $7.72 | 33.47% | 10.85x | 9.48x | 4.48x | 2.81x | 0.95x | $82.01M | 13.44% | $217.65M | 3.68 | $468.42M | 6.06 | ||
| TGTX | TG THERAPEUTICS INC | $57.40 | $22.74 | 152.37% | 18.64x | 55.99x | 10.18x | 14.54x | 2.08x | $17.39M | 0.21% | $604.08M | 4.26 | $9.05B | 65.04 | ||
| ADMA | ADMA BIOLOGICS INC | $11.28 | $7.08 | 59.28% | 15.67x | 14.18x | 5.02x | 6.19x | 0.91x | $116.47M | 4.52% | $408.21M | 1.79 | $2.59B | 11.11 | ||
| EXEL | EXELIXIS INC | $66.28 | $30.87 | 114.68% | 20.15x | 20.09x | 6.82x | 8.91x | 1.29x | $1.17B | 7.05% | $1.84B | 7.35 | $16.31B | 14.99 | ||
| MDXG | MIMEDX GROUP INC | $3.95 | $1.18 | 235.00% | 98.75x | -21.92x | 1.64x | 2.67x | 1.19x | $44.50M | 7.62% | $216.00M | 1.46 | $457.12M | 20.04 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $318.78 | $87.59 | 263.95% | 31.66x | 33.59x | 22.01x | 6.57x | 2.37x | $130.62M | 2.04% | $967.52M | 48.22 | $6.48B | 23.23 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $205.06 | $192.44 | 6.56% | 13.44x | 13.47x | 2.82x | 2.77x | 0.51x | $1.62B | 12.50% | $4.80B | 75.98 | $16.09B | 9.95 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $529.69 | $150.41 | 252.16% | 30.56x | 27.73x | 10.68x | 6.63x | 2.30x | $3.80B | 2.82% | $20.25B | 79.81 | $130.09B | 23.64 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.50 | $31.49 | 22.28% | 12.26x | 9.25x | 2.32x | 2.24x | 0.69x | $354.90M | 15.91% | $999.24M | 17.25 | $1.85B | 6.59 | ||
| UTHR | UNITED THERAPEUTICS CORP | $586.48 | $210.21 | 179.00% | 19.39x | 21.65x | 7.92x | 3.93x | 2.58x | $1.09B | 4.37% | $6.40B | 150.24 | $23.35B | 13.93 | ||
| TECH | BIO-TECHNE CORP | $72.69 | $16.56 | 339.05% | 62.13x | 34.99x | 9.33x | 5.41x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.86 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $813.27 | $434.78 | 87.05% | 19.39x | 13.59x | 5.38x | 2.64x | 1.02x | $3.76B | 4.50% | $31.71B | 308.48 | $83.98B | 14.61 | ||
| VCYT | VERACYTE INC | $50.31 | $11.88 | 323.51% | 34.94x | 25.94x | 7.16x | 2.91x | 2.95x | $165.99M | 4.13% | $1.39B | 17.36 | $3.78B | 27.09 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.17 | $1.41 | -16.95% | 8.36x | -2.64x | 1.44x | 1.54x | 0.47x | $19.58M | 28.89% | $44.20M | 0.76 | $19.40M | 2.54 | ||
| INCY | INCYTE CORP | $116.87 | $58.67 | 99.21% | 14.39x | 36.92x | 4.02x | 3.73x | 1.71x | $1.92B | 8.20% | $6.34B | 31.66 | $19.74B | 9.54 |